Amneal reprices term loan, cuts interest margin 50 bps on USD 2.08 billion facility

Reuters2026/08/03 20:40

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Amneal repriced its term loan facility via Amendment No. 3 to its November 2023 credit agreement with JPMorgan Chase as administrative agent.
Consenting lenders converted existing term loans into new loans totaling USD 2.04 billion; Amneal added a USD 45.2 million term loan to repay non-consenting lenders.
Interest margins drop 50 bps to 1.5% over base rate or 2.5% over SOFR; maturity stays Aug. 1, 2032.
Repricing transactions avoid a prepayment premium if completed after Feb. 3, 2027.
Annualized cash interest savings estimated at about USD 12 million versus the prior terms.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Amneal Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-051900), on August 03, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Amneal reprices term loan, cuts interest margin 50 bps on USD 2.08 billion facility

You may also like

Crypto prices